Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Josep Manyé"'
Autor:
Anna Carrasco, Eva Tristán, Fernando Fernández‐Bañares, Albert Martín‐Cardona, Montserrat Aceituno, Yamile Zabana, Lourdes Fluvià, José María Hernández, Violeta Lorén, Josep Manyé, Antonio Salas, Xavier Andújar, Carme Loras, Maria Esteve
Publikováno v:
Immunity, Inflammation and Disease, Vol 10, Iss 10, Pp n/a-n/a (2022)
Abstract Background Previous studies suggested that Interleukin‐10 (IL‐10) depletion in Crohn's disease (CD) could predict outcome. Aim: To determine IL‐10 in blood and at different intestinal locations in patients with active CD and to assess
Externí odkaz:
https://doaj.org/article/8e9bc48e94a8473f96d8e1e27cda2a7f
Autor:
Sara Morón-López, Maria C Puertas, Cristina Gálvez, Jordi Navarro, Anna Carrasco, Maria Esteve, Josep Manyé, Manel Crespo, Maria Salgado, Javier Martinez-Picado
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175899 (2017)
BACKGROUND:The implementation of successful strategies to achieve an HIV cure has become a priority in HIV research. However, the current location and size of HIV reservoirs is still unknown since there are limited tools to evaluate HIV latency in vi
Externí odkaz:
https://doaj.org/article/4a971e7f2aa2427893b4f5853220e5b3
Autor:
Violeta Lorén, Eduard Cabré, Isabel Ojanguren, Eugeni Domènech, Elisabet Pedrosa, Arce García-Jaraquemada, Miriam Mañosa, Josep Manyé
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130921 (2015)
Glucocorticosteroids are the first line therapy for moderate-severe flare-ups of ulcerative colitis. Despite that, up to 60% of patients do not respond adequately to steroid treatment. Previously, we reported that low IL-10 mRNA levels in intestine a
Externí odkaz:
https://doaj.org/article/990ad43cbf6e418da0dc1e14ce1a9cac
Autor:
Roger Suau, Anna Garcia, Carla Bernal, Mariona Llaves, Katharina Schiering, Eva Jou-Ollé, Alex Pertegaz, Arce Garcia-Jaraquemada, Ramon Bartolí, Violeta Lorén, Patri Vergara, Míriam Mañosa, Eugeni Domènech, Josep Manyé
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 7; Pages: 6424
The lack of knowledge regarding the pathogenesis of IBD is a challenge for the development of more effective and safer therapies. Although in vivo preclinical approaches are critical for drug testing, none of the existing models accurately reproduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a253576731a6c3e9b937f5a4ba75440
https://ddd.uab.cat/record/274413
https://ddd.uab.cat/record/274413
